Patients with polymorphic light eruption have decreased serum levels of 25-hydroxyvitamin-D3 that increase upon 311 nm UVB photohardening View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-12

AUTHORS

Alexandra Gruber-Wackernagel, Barbara Obermayer-Pietsch, Scott N. Byrne, Peter Wolf

ABSTRACT

Background: Polymorphic light eruption (PLE) is a very common condition whose pathogenesis may involve immunological abnormalities. Vitamin D sufficiency is thought to be important for normal immune function. Objective: To determine whether PLE patients are vitamin D deficient and to study how photohardening with 311 nm UVB affects the vitamin D status of PLE patients. Methods: The vitamin D status of 23 PLE patients (21 females and 2 males; age range, 18–55 years) was analysed at four different time points (early spring, late spring, summer, and winter) by measuring 25-hydroxyvitamin-D3 (25(OH)D) serum levels through a standardised immunoassay. Fifteen of those patients received 311 nm UVB in early spring for prevention of PLE symptoms. 25(OH)D levels of the PLE patients were compared to that of 23 sex-, age-, and body-mass-index post hoc-matched control subjects. Results: PLE patients had low levels of 25(OH)D throughout the year compared to that of the control subjects. At baseline in early spring, the mean ± SD 25(OH)D level was 14.9 ± 3.0 ng ml−1 in the PLE patients that would later receive 311 nm UVB and 14.4 ± 2.4 ng ml−1 in the patients not receiving 311 nm UVB. Successful prophylactic treatment with 311 nm UVB significantly increased 25(OH)D levels to a mean of 21.0 ± 3.4 ng ml−1 (p < 0.001; ANOVA, Tukey’s test). Heading into summer, the 25(OH)D levels in treated patients decreased again, reaching their lowest levels in winter. In contrast, the 25(OH)D levels of untreated PLE patients stayed in the low range in early and late spring but increased by trend towards summer, reaching similar levels to that of the PLE patients who had received 311 nm UVB (17.1 ± 2.3 vs. 17.3 ± 6.0 ng ml−1). Like the treated PLE patients, 25(OH)D levels of untreated patients significantly decreased in winter to comparable levels (12.2 ± 1.9 vs. 13.8 ± 1.8 ng ml−1). Taken together, the 25(OH)D levels of PLE patients were significantly lower at all time points than that observed in the matched control population (34.4 ± 12.5 ng ml−1) (p < 0.000003). Conclusions: PLE patients have low 25(OH)D serum levels. 311 nm UVB phototherapy that prevented PLE symptoms increased those levels. Thus, we speculate that boosting levels of vitamin D may be important in ameliorating PLE. More... »

PAGES

1831-1836

Identifiers

URI

http://scigraph.springernature.com/pub.10.1039/c2pp25188d

DOI

http://dx.doi.org/10.1039/c2pp25188d

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034994234

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22952008


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/02", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0299", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Other Physical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0306", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Chemistry (incl. Structural)", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcifediol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Photosensitivity Disorders", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Seasons", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Skin Diseases, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ultraviolet Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Research Unit for Photodermatology, Department of Dermatology, Medical University of Graz, Auenbrugger Platz 8, A-8036, Graz, Austria", 
          "id": "http://www.grid.ac/institutes/grid.11598.34", 
          "name": [
            "Research Unit for Photodermatology, Department of Dermatology, Medical University of Graz, Auenbrugger Platz 8, A-8036, Graz, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gruber-Wackernagel", 
        "givenName": "Alexandra", 
        "id": "sg:person.0674636105.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674636105.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Nuclear Medicine, Department of Internal Medicine, Medical University of Graz, Austria", 
          "id": "http://www.grid.ac/institutes/grid.11598.34", 
          "name": [
            "Division of Endocrinology and Nuclear Medicine, Department of Internal Medicine, Medical University of Graz, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Obermayer-Pietsch", 
        "givenName": "Barbara", 
        "id": "sg:person.01071524655.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071524655.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Infectious Diseases and Immunology, Sydney Medical School, The University of Sydney, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1013.3", 
          "name": [
            "Department of Infectious Diseases and Immunology, Sydney Medical School, The University of Sydney, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Byrne", 
        "givenName": "Scott N.", 
        "id": "sg:person.01326544127.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326544127.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Unit for Photodermatology, Department of Dermatology, Medical University of Graz, Auenbrugger Platz 8, A-8036, Graz, Austria", 
          "id": "http://www.grid.ac/institutes/grid.11598.34", 
          "name": [
            "Research Unit for Photodermatology, Department of Dermatology, Medical University of Graz, Auenbrugger Platz 8, A-8036, Graz, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wolf", 
        "givenName": "Peter", 
        "id": "sg:person.0745631531.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745631531.42"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ncprheum0989", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035519593", 
          "https://doi.org/10.1038/ncprheum0989"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1039/c2pp25187f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020875604", 
          "https://doi.org/10.1039/c2pp25187f"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1039/c1pp05009e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043187191", 
          "https://doi.org/10.1039/c1pp05009e"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri3045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009220184", 
          "https://doi.org/10.1038/nri3045"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1518", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023391736", 
          "https://doi.org/10.1038/nm1518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00403-003-0387-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075274222", 
          "https://doi.org/10.1007/s00403-003-0387-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-12", 
    "datePublishedReg": "2012-12-01", 
    "description": "Background: Polymorphic light eruption (PLE) is a very common condition whose pathogenesis may involve immunological abnormalities. Vitamin D sufficiency is thought to be important for normal immune function. Objective: To determine whether PLE patients are vitamin D deficient and to study how photohardening with 311 nm UVB affects the vitamin D status of PLE patients. Methods: The vitamin D status of 23 PLE patients (21 females and 2 males; age range, 18\u201355 years) was analysed at four different time points (early spring, late spring, summer, and winter) by measuring 25-hydroxyvitamin-D3 (25(OH)D) serum levels through a standardised immunoassay. Fifteen of those patients received 311 nm UVB in early spring for prevention of PLE symptoms. 25(OH)D levels of the PLE patients were compared to that of 23 sex-, age-, and body-mass-index post hoc-matched control subjects. Results: PLE patients had low levels of 25(OH)D throughout the year compared to that of the control subjects. At baseline in early spring, the mean \u00b1 SD 25(OH)D level was 14.9 \u00b1 3.0 ng ml\u22121 in the PLE patients that would later receive 311 nm UVB and 14.4 \u00b1 2.4 ng ml\u22121 in the patients not receiving 311 nm UVB. Successful prophylactic treatment with 311 nm UVB significantly increased 25(OH)D levels to a mean of 21.0 \u00b1 3.4 ng ml\u22121 (p < 0.001; ANOVA, Tukey\u2019s test). Heading into summer, the 25(OH)D levels in treated patients decreased again, reaching their lowest levels in winter. In contrast, the 25(OH)D levels of untreated PLE patients stayed in the low range in early and late spring but increased by trend towards summer, reaching similar levels to that of the PLE patients who had received 311 nm UVB (17.1 \u00b1 2.3 vs. 17.3 \u00b1 6.0 ng ml\u22121). Like the treated PLE patients, 25(OH)D levels of untreated patients significantly decreased in winter to comparable levels (12.2 \u00b1 1.9 vs. 13.8 \u00b1 1.8 ng ml\u22121). Taken together, the 25(OH)D levels of PLE patients were significantly lower at all time points than that observed in the matched control population (34.4 \u00b1 12.5 ng ml\u22121) (p < 0.000003). Conclusions: PLE patients have low 25(OH)D serum levels. 311 nm UVB phototherapy that prevented PLE symptoms increased those levels. Thus, we speculate that boosting levels of vitamin D may be important in ameliorating PLE.", 
    "genre": "article", 
    "id": "sg:pub.10.1039/c2pp25188d", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7580457", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1029729", 
        "issn": [
          "1474-905X", 
          "1474-9092"
        ], 
        "name": "Photochemical & Photobiological Sciences", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "keywords": [
      "polymorphic light eruption", 
      "PLE patients", 
      "vitamin D status", 
      "serum levels", 
      "PLE symptoms", 
      "D status", 
      "light eruption", 
      "vitamin D", 
      "control subjects", 
      "vitamin D sufficiency", 
      "time points", 
      "normal immune function", 
      "successful prophylactic treatment", 
      "immunological abnormalities", 
      "D sufficiency", 
      "untreated patients", 
      "different time points", 
      "UVB phototherapy", 
      "prophylactic treatment", 
      "common condition", 
      "immune function", 
      "patients", 
      "control population", 
      "low levels", 
      "UVB", 
      "symptoms", 
      "comparable levels", 
      "similar levels", 
      "subjects", 
      "status", 
      "levels", 
      "pathogenesis", 
      "abnormalities", 
      "baseline", 
      "phototherapy", 
      "photohardening", 
      "prevention", 
      "age", 
      "sex", 
      "treatment", 
      "SD", 
      "immunoassay", 
      "lower range", 
      "population", 
      "years", 
      "eruption", 
      "index", 
      "contrast", 
      "function", 
      "means", 
      "sufficiency", 
      "point", 
      "trends", 
      "conditions", 
      "range", 
      "early spring", 
      "winter", 
      "spring", 
      "summer", 
      "late spring"
    ], 
    "name": "Patients with polymorphic light eruption have decreased serum levels of 25-hydroxyvitamin-D3 that increase upon 311 nm UVB photohardening", 
    "pagination": "1831-1836", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034994234"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1039/c2pp25188d"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22952008"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1039/c2pp25188d", 
      "https://app.dimensions.ai/details/publication/pub.1034994234"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_580.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1039/c2pp25188d"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1039/c2pp25188d'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1039/c2pp25188d'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1039/c2pp25188d'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1039/c2pp25188d'


 

This table displays all metadata directly associated to this object as RDF triples.

237 TRIPLES      21 PREDICATES      108 URIs      90 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1039/c2pp25188d schema:about N1051004e031d4993b195934bb3e1a4fd
2 N151b21d067d2497d87c9c610d80c1387
3 N4538ef4fd90848f9a22351dcca9980d8
4 N49367d2c6226470aae606f85f181d4c7
5 N64ff901060b54247a260007ed2398c09
6 N80fc5be6a0b54abfaa3ad6b8a24f4c4d
7 N908ab29aada74ed8a1780e02ff2ec176
8 N9c943587ad814ae9a0960b94e2b3f140
9 Nad706015b3184b80b87210bea149fb17
10 Ncd730e41aad74b5cb7ca8a6b43473698
11 Ne5b8417cfbe64145abeb32723337c623
12 Nf8ce8019bbaf4c3dba4ded31579ff662
13 anzsrc-for:02
14 anzsrc-for:0299
15 anzsrc-for:03
16 anzsrc-for:0306
17 anzsrc-for:06
18 anzsrc-for:0601
19 schema:author N444cc591c1d2425190a584b8d525174b
20 schema:citation sg:pub.10.1007/s00403-003-0387-6
21 sg:pub.10.1038/ncprheum0989
22 sg:pub.10.1038/nm1518
23 sg:pub.10.1038/nri3045
24 sg:pub.10.1039/c1pp05009e
25 sg:pub.10.1039/c2pp25187f
26 schema:datePublished 2012-12
27 schema:datePublishedReg 2012-12-01
28 schema:description Background: Polymorphic light eruption (PLE) is a very common condition whose pathogenesis may involve immunological abnormalities. Vitamin D sufficiency is thought to be important for normal immune function. Objective: To determine whether PLE patients are vitamin D deficient and to study how photohardening with 311 nm UVB affects the vitamin D status of PLE patients. Methods: The vitamin D status of 23 PLE patients (21 females and 2 males; age range, 18–55 years) was analysed at four different time points (early spring, late spring, summer, and winter) by measuring 25-hydroxyvitamin-D3 (25(OH)D) serum levels through a standardised immunoassay. Fifteen of those patients received 311 nm UVB in early spring for prevention of PLE symptoms. 25(OH)D levels of the PLE patients were compared to that of 23 sex-, age-, and body-mass-index post hoc-matched control subjects. Results: PLE patients had low levels of 25(OH)D throughout the year compared to that of the control subjects. At baseline in early spring, the mean ± SD 25(OH)D level was 14.9 ± 3.0 ng ml−1 in the PLE patients that would later receive 311 nm UVB and 14.4 ± 2.4 ng ml−1 in the patients not receiving 311 nm UVB. Successful prophylactic treatment with 311 nm UVB significantly increased 25(OH)D levels to a mean of 21.0 ± 3.4 ng ml−1 (p < 0.001; ANOVA, Tukey’s test). Heading into summer, the 25(OH)D levels in treated patients decreased again, reaching their lowest levels in winter. In contrast, the 25(OH)D levels of untreated PLE patients stayed in the low range in early and late spring but increased by trend towards summer, reaching similar levels to that of the PLE patients who had received 311 nm UVB (17.1 ± 2.3 vs. 17.3 ± 6.0 ng ml−1). Like the treated PLE patients, 25(OH)D levels of untreated patients significantly decreased in winter to comparable levels (12.2 ± 1.9 vs. 13.8 ± 1.8 ng ml−1). Taken together, the 25(OH)D levels of PLE patients were significantly lower at all time points than that observed in the matched control population (34.4 ± 12.5 ng ml−1) (p < 0.000003). Conclusions: PLE patients have low 25(OH)D serum levels. 311 nm UVB phototherapy that prevented PLE symptoms increased those levels. Thus, we speculate that boosting levels of vitamin D may be important in ameliorating PLE.
29 schema:genre article
30 schema:isAccessibleForFree false
31 schema:isPartOf N63f10ade5e554975a9505928ad77762c
32 N8a8e0c3a6d6240798cbb866257b93baf
33 sg:journal.1029729
34 schema:keywords D status
35 D sufficiency
36 PLE patients
37 PLE symptoms
38 SD
39 UVB
40 UVB phototherapy
41 abnormalities
42 age
43 baseline
44 common condition
45 comparable levels
46 conditions
47 contrast
48 control population
49 control subjects
50 different time points
51 early spring
52 eruption
53 function
54 immune function
55 immunoassay
56 immunological abnormalities
57 index
58 late spring
59 levels
60 light eruption
61 low levels
62 lower range
63 means
64 normal immune function
65 pathogenesis
66 patients
67 photohardening
68 phototherapy
69 point
70 polymorphic light eruption
71 population
72 prevention
73 prophylactic treatment
74 range
75 serum levels
76 sex
77 similar levels
78 spring
79 status
80 subjects
81 successful prophylactic treatment
82 sufficiency
83 summer
84 symptoms
85 time points
86 treatment
87 trends
88 untreated patients
89 vitamin D
90 vitamin D status
91 vitamin D sufficiency
92 winter
93 years
94 schema:name Patients with polymorphic light eruption have decreased serum levels of 25-hydroxyvitamin-D3 that increase upon 311 nm UVB photohardening
95 schema:pagination 1831-1836
96 schema:productId N18f42e56b30f46b6b1190d16b7af90eb
97 N8ce5fc5c022449baaecbadc07290a79d
98 Nd9c45891070046c6a44335d360411c96
99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034994234
100 https://doi.org/10.1039/c2pp25188d
101 schema:sdDatePublished 2022-10-01T06:38
102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
103 schema:sdPublisher N6c1c5b6e9639474ebe96a4756481edb0
104 schema:url https://doi.org/10.1039/c2pp25188d
105 sgo:license sg:explorer/license/
106 sgo:sdDataset articles
107 rdf:type schema:ScholarlyArticle
108 N1051004e031d4993b195934bb3e1a4fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Adolescent
110 rdf:type schema:DefinedTerm
111 N151b21d067d2497d87c9c610d80c1387 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Male
113 rdf:type schema:DefinedTerm
114 N18f42e56b30f46b6b1190d16b7af90eb schema:name doi
115 schema:value 10.1039/c2pp25188d
116 rdf:type schema:PropertyValue
117 N444cc591c1d2425190a584b8d525174b rdf:first sg:person.0674636105.22
118 rdf:rest Nde38ab94871949749e001a19ca7c8eff
119 N4538ef4fd90848f9a22351dcca9980d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Female
121 rdf:type schema:DefinedTerm
122 N49367d2c6226470aae606f85f181d4c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Calcifediol
124 rdf:type schema:DefinedTerm
125 N63f10ade5e554975a9505928ad77762c schema:volumeNumber 11
126 rdf:type schema:PublicationVolume
127 N64ff901060b54247a260007ed2398c09 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Young Adult
129 rdf:type schema:DefinedTerm
130 N6c1c5b6e9639474ebe96a4756481edb0 schema:name Springer Nature - SN SciGraph project
131 rdf:type schema:Organization
132 N80fc5be6a0b54abfaa3ad6b8a24f4c4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Ultraviolet Therapy
134 rdf:type schema:DefinedTerm
135 N8a8e0c3a6d6240798cbb866257b93baf schema:issueNumber 12
136 rdf:type schema:PublicationIssue
137 N8ce5fc5c022449baaecbadc07290a79d schema:name dimensions_id
138 schema:value pub.1034994234
139 rdf:type schema:PropertyValue
140 N908ab29aada74ed8a1780e02ff2ec176 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Seasons
142 rdf:type schema:DefinedTerm
143 N9b85fcc6ca3449739816a6305236346f rdf:first sg:person.01326544127.56
144 rdf:rest Nb21752b05ab64f4eb78afcc51e708d13
145 N9c943587ad814ae9a0960b94e2b3f140 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Adult
147 rdf:type schema:DefinedTerm
148 Nad706015b3184b80b87210bea149fb17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Skin Diseases, Genetic
150 rdf:type schema:DefinedTerm
151 Nb21752b05ab64f4eb78afcc51e708d13 rdf:first sg:person.0745631531.42
152 rdf:rest rdf:nil
153 Ncd730e41aad74b5cb7ca8a6b43473698 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Humans
155 rdf:type schema:DefinedTerm
156 Nd9c45891070046c6a44335d360411c96 schema:name pubmed_id
157 schema:value 22952008
158 rdf:type schema:PropertyValue
159 Nde38ab94871949749e001a19ca7c8eff rdf:first sg:person.01071524655.82
160 rdf:rest N9b85fcc6ca3449739816a6305236346f
161 Ne5b8417cfbe64145abeb32723337c623 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Middle Aged
163 rdf:type schema:DefinedTerm
164 Nf8ce8019bbaf4c3dba4ded31579ff662 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Photosensitivity Disorders
166 rdf:type schema:DefinedTerm
167 anzsrc-for:02 schema:inDefinedTermSet anzsrc-for:
168 schema:name Physical Sciences
169 rdf:type schema:DefinedTerm
170 anzsrc-for:0299 schema:inDefinedTermSet anzsrc-for:
171 schema:name Other Physical Sciences
172 rdf:type schema:DefinedTerm
173 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
174 schema:name Chemical Sciences
175 rdf:type schema:DefinedTerm
176 anzsrc-for:0306 schema:inDefinedTermSet anzsrc-for:
177 schema:name Physical Chemistry (incl. Structural)
178 rdf:type schema:DefinedTerm
179 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
180 schema:name Biological Sciences
181 rdf:type schema:DefinedTerm
182 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
183 schema:name Biochemistry and Cell Biology
184 rdf:type schema:DefinedTerm
185 sg:grant.7580457 http://pending.schema.org/fundedItem sg:pub.10.1039/c2pp25188d
186 rdf:type schema:MonetaryGrant
187 sg:journal.1029729 schema:issn 1474-905X
188 1474-9092
189 schema:name Photochemical & Photobiological Sciences
190 schema:publisher Springer Nature
191 rdf:type schema:Periodical
192 sg:person.01071524655.82 schema:affiliation grid-institutes:grid.11598.34
193 schema:familyName Obermayer-Pietsch
194 schema:givenName Barbara
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071524655.82
196 rdf:type schema:Person
197 sg:person.01326544127.56 schema:affiliation grid-institutes:grid.1013.3
198 schema:familyName Byrne
199 schema:givenName Scott N.
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326544127.56
201 rdf:type schema:Person
202 sg:person.0674636105.22 schema:affiliation grid-institutes:grid.11598.34
203 schema:familyName Gruber-Wackernagel
204 schema:givenName Alexandra
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674636105.22
206 rdf:type schema:Person
207 sg:person.0745631531.42 schema:affiliation grid-institutes:grid.11598.34
208 schema:familyName Wolf
209 schema:givenName Peter
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745631531.42
211 rdf:type schema:Person
212 sg:pub.10.1007/s00403-003-0387-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075274222
213 https://doi.org/10.1007/s00403-003-0387-6
214 rdf:type schema:CreativeWork
215 sg:pub.10.1038/ncprheum0989 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035519593
216 https://doi.org/10.1038/ncprheum0989
217 rdf:type schema:CreativeWork
218 sg:pub.10.1038/nm1518 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023391736
219 https://doi.org/10.1038/nm1518
220 rdf:type schema:CreativeWork
221 sg:pub.10.1038/nri3045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009220184
222 https://doi.org/10.1038/nri3045
223 rdf:type schema:CreativeWork
224 sg:pub.10.1039/c1pp05009e schema:sameAs https://app.dimensions.ai/details/publication/pub.1043187191
225 https://doi.org/10.1039/c1pp05009e
226 rdf:type schema:CreativeWork
227 sg:pub.10.1039/c2pp25187f schema:sameAs https://app.dimensions.ai/details/publication/pub.1020875604
228 https://doi.org/10.1039/c2pp25187f
229 rdf:type schema:CreativeWork
230 grid-institutes:grid.1013.3 schema:alternateName Department of Infectious Diseases and Immunology, Sydney Medical School, The University of Sydney, Australia
231 schema:name Department of Infectious Diseases and Immunology, Sydney Medical School, The University of Sydney, Australia
232 rdf:type schema:Organization
233 grid-institutes:grid.11598.34 schema:alternateName Division of Endocrinology and Nuclear Medicine, Department of Internal Medicine, Medical University of Graz, Austria
234 Research Unit for Photodermatology, Department of Dermatology, Medical University of Graz, Auenbrugger Platz 8, A-8036, Graz, Austria
235 schema:name Division of Endocrinology and Nuclear Medicine, Department of Internal Medicine, Medical University of Graz, Austria
236 Research Unit for Photodermatology, Department of Dermatology, Medical University of Graz, Auenbrugger Platz 8, A-8036, Graz, Austria
237 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...